The Latest Breaking News from Pfizer

Paris (AFP) - After two years of racing to vaccinate the world against Covid-19, the number of available doses now surpasses demand in many areas.

Last December, we reported on the threatening behavior of a group of anti-vaccine activists toward Kristina Lawson, the president of the Medical Board of California.

The Therapeutic Goods Administration has approved the Pfizer COVID booster for people aged 12 to 15, but it will need a final tick of approval before it is made available to the cohort.

Egypt has received 1.5 million doses of Pfizer’s coronavirus vaccine donated by the US government. Acting Health Minister Khaled Abdel Ghaffar said Egypt received 1,501,110 Pfizer COVID-19 vaccine doses gifted by the US and delivered through the COVAX initiative and in cooperation with the Vaccine Alliance (GAVI). The new batch…

Pfizer Inc (NYSE: PFE) shares are trading higher Thursday. The company announced the acquisition of ReViral for a total consideration of up to $525 million.

Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.

Pfizer Inc (NYSE: PFE) 

Pfizer will buy privately held RSV treatment-maker ReViral for up to $525 million, the company said early Thursday. And Pfizer stock rose.

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Omicron variant and and anti-vaccine backlash are complicating the effort.

A fourth shot of the Pfizer COVID-19 vaccine increased protection against viral infection for only four to seven weeks, according to a massive study published Tuesday.